AC

Alfredo C. Castro

IP Infinity Pharmaceuticals: 63 patents #1 of 76Top 2%
IO Ikena Oncology: 14 patents #1 of 13Top 8%
ID Infinity Discovery: 11 patents #1 of 27Top 4%
BI Biogen: 9 patents #10 of 174Top 6%
CT Cyteir Therapeutics: 6 patents #3 of 7Top 45%
SA Sanofi-Aventis: 2 patents #437 of 1,008Top 45%
SP Syntonix Pharmaceuticals: 1 patents #15 of 17Top 90%
AG Aventis Pharma Deutschland Gmbh: 1 patents #209 of 418Top 50%
BH Biogen Idec Hemophilia: 1 patents #7 of 18Top 40%
BM Biogen Idec Ma: 1 patents #173 of 270Top 65%
MP Millennium Pharmaceuticals: 1 patents #496 of 771Top 65%
AS Askat: 1 patents #10 of 21Top 50%
Overall (All Time): #11,246 of 4,157,543Top 1%
113
Patents All Time

Issued Patents All Time

Showing 25 most recent of 113 patents

Patent #TitleCo-InventorsDate
12295962 Polymorphic compounds and uses thereof David Jonaitis 2025-05-13
12162884 Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine as aryl hydrocarbon receptor (AHR) inhibitors James Martin Nolan, III, Sarah Bethune, Corinne Marie Folberth 2024-12-10
12152032 Heterocyclic compounds and uses thereof Catherine A. Evans, Somarajannair Janardanannair, Andre Lescarbeau, Tao Liu, Martin Tremblay 2024-11-26
12077542 Indole AHR inhibitors and uses thereof Catherine A. Evans 2024-09-03
12064419 Methods of using RAD51 inhibitors for treatment of pancreatic cancer Melinda DAY, Tyler MACLAY, Casey Cameron McComas, Kevin MILLS, Joseph P. Vacca 2024-08-20
12030876 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Karen J. McGovern, Michael J. Burke 2024-07-09
11925651 TEAD inhibitors and uses thereof 2024-03-12
11878958 MEK inhibitors and uses thereof Michael J. Burke, Thomas Andrew Wynn, Sabine K. Ruppel, Sergio L. Santillana Soto, Eric HAINES +2 more 2024-01-23
11760728 Tead inhibitors and uses thereof 2023-09-19
11607404 Combinations of RAD51 and PARP inhibitors Melinda DAY, Tyler MACLAY, Casey Cameron McComas, Kevin MILLS, Joseph P. Vacca 2023-03-21
11608329 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Karen J. McGovern, Michael J. Burke 2023-03-21
11602527 Methods of use of cyclopamine analogs Michael J. Grogan, Karen J. McGovern, Martin Tremblay 2023-03-14
11591339 Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate as aryl hydrocarbon receptor (AHR) inhibitors James Martin Nolan, III, Sarah Bethune, Corinne Marie Folberth 2023-02-28
11555026 AHR inhibitors and uses thereof Catherine A. Evans 2023-01-17
11541059 Heterocyclic compounds and uses thereof Jeffery L. Kutok, David G. Winkler, Vito J. Palombella, Catherine A. Evans, Somarajannair Janardanannair +3 more 2023-01-03
11458149 TEAD inhibitors and uses thereof 2022-10-04
11358969 Indole AHR inhibitors and uses thereof Catherine A. Evans 2022-06-14
11291655 RAD51 inhibitors Casey Cameron McComas, Joseph P. Vacca 2022-04-05
11274082 Tead inhibitors and uses thereof 2022-03-15
11084812 RAD51 inhibitors Casey Cameron McComas, Joseph P. Vacca, Tyler MACLAY 2021-08-10
11007181 Cyclopamine analogs Brian C. Austad, Mark Behnke, Michael J. Grogan, Somarajannair Janardanannair, Andre Lescarbeau +3 more 2021-05-18
10941162 Heterocyclic compounds and uses thereof Catherine A. Evans, Martin Tremblay 2021-03-09
10821102 Methods of use of cyclopamine analogs Michael J. Grogan, Karen J. McGovern, Martin Tremblay 2020-11-03
10696650 AHR inhibitors and uses thereof Catherine A. Evans 2020-06-30
10689388 Indole AHR inhibitors and uses thereof Catherine A. Evans 2020-06-23